Aklile Workneh
Overview
Explore the profile of Aklile Workneh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lenet T, Baker L, Vered M, Workneh A, Zahrai A, Rajendran L, et al.
Br J Surg
. 2022 Nov;
110(2):269-270.
PMID: 36448200
No abstract available.
12.
Endo Y, Alaimo L, Lima H, Moazzam Z, Ratti F, Marques H, et al.
Ann Surg Oncol
. 2022 Sep;
30(2):725-733.
PMID: 36103014
Background: The presence of microvascular invasion (MVI) has been highlighted as an important determinant of hepatocellular carcinoma (HCC) prognosis. We sought to build and validate a novel model to predict...
13.
Park L, Daza J, Li V, Workneh A, Zuk V, Claasen M, et al.
J Surg Oncol
. 2022 Jan;
125(5):872-879.
PMID: 35050522
Background: The clinical course of patients experiencing recurrence following hepatectomy for colorectal cancer metastases (CRM) is poorly defined. Previous studies associated shorter time to recurrence (TTR) in months, node-positive primary...
14.
Zhang X, Xue F, Bagante F, Ratti F, Marques H, Silva S, et al.
J Gastrointest Surg
. 2021 Nov;
26(5):1021-1029.
PMID: 34797558
Objectives: To identify the preoperative risk factors for prediction of non-transplantable recurrence (NTR) after tumor resection for early-stage hepatocellular carcinoma (HCC) to assist in patient selection relative to upfront liver...
15.
Wei T, Zhang X, Bagante F, Ratti F, Marques H, Silva S, et al.
Ann Surg Oncol
. 2021 Aug;
29(1):315-324.
PMID: 34378089
Background: Postoperative infectious complications may be associated with a worse long-term prognosis for patients undergoing surgery for a malignant indication. The current study aimed to characterize the impact of postoperative...
16.
Elfadaly A, Tsilimigras D, Hyer J, Paro A, Bagante F, Ratti F, et al.
World J Surg
. 2021 Aug;
45(11):3438-3448.
PMID: 34341844
Background: The impact of tumor burden score (TBS) on conditional survival (CS) among patients undergoing curative-intent resection of hepatocellular carcinoma (HCC) has not been examined to date. Methods: Patients who...
17.
Wei T, Zhang X, Xue F, Bagante F, Ratti F, Marques H, et al.
Ann Surg Oncol
. 2021 May;
28(12):7624-7633.
PMID: 34019181
Backgrounds: Extrahepatic recurrence of hepatocellular carcinoma (HCC) after surgical resection is associated with unfavorable prognosis. The objectives of the current study were to identify the risk factors and develop a...
18.
Tsilimigras D, Moris D, Hyer J, Bagante F, Ratti F, Marques H, et al.
Ann Surg Oncol
. 2021 Apr;
28(12):7673-7683.
PMID: 33907924
Introduction: Although preoperative α-fetoprotein (AFP) has been recognized as an important tumor marker among patients with hepatocellular carcinoma (HCC), the predictive value of AFP levels at the time of recurrence...
19.
Tsilimigras D, Hyer J, Diaz A, Bagante F, Ratti F, Marques H, et al.
Cancers (Basel)
. 2021 Mar;
13(4).
PMID: 33670174
Introduction: The prognostic role of tumor burden score (TBS) relative to pre-operative α -fetoprotein (AFP) levels among patients undergoing curative-intent resection of HCC has not been examined. Methods: Patients who...
20.
Wei T, Zhang X, Bagante F, Ratti F, Marques H, Silva S, et al.
Ann Surg Oncol
. 2020 Nov;
28(2):797-805.
PMID: 33249525
Background: The impact of tumor necrosis relative to prognosis among patients undergoing curative-intent resection for hepatocellular carcinoma (HCC) remains ill-defined. Methods: Patients who underwent curative-intent resection for HCC without any...